Immunogenicity of Two Doses of ChAdOx1 nCoV-19 Vaccine in Lung Transplant Recipients

PURPOSE: Lung transplant recipients (LTR) are at higher risk to develop severe SARS-CoV2 pneumonia, due to the immunosuppressive regimen, which further hampers their immune response to vaccination. Indeed, is has been shown that LTR mount weak antibody response after SARS-CoV2 mRNA vaccination. Neve...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlier, F.M., Closset, M., Catry, E., Dumonceaux, M., Douxfils, J., Frérotte, D., Evrard, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(295)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988587/
http://dx.doi.org/10.1016/j.healun.2022.01.316

Ejemplares similares

Ejemplares similares